MohamedKamelMohamedMDPhD

Hematologic Oncology, Melanoma, Thoracic Cancer

Division Director Medical Oncology, Cone Health Cancer Center Director of Thoracic Oncology, Cone Health Cancer Center, Greensboro, NC

Join to view full profile

Dr. Mohamed is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Mohamed's full profile

Already have an account?

Office
2400 West Friendly Ave
Greensboro, NC 27403
Phone+1 336-832-1100

Fax+1 336-832-0770
Is this information wrong?

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2002 - 2005
Vidant Medical Center/East Carolina UniversityResidency, Internal Medicine, 1999 - 2002
Ain Shams University Faculty of MedicineClass of 1984

Certifications & Licensure

NC State Medical License 1999 - 2025
PA State Medical License 2002 - 2006
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013

Clinical Trials

A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib Start of enrollment: 2012 Oct 01
Completed
Phase 1, Phase 2

Publications & Presentations

PubMed

39 citations
Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: ECOG-ACRIN 5508
Suresh S. Ramalingam, Suzanne E. Dahlberg, Chandra P. Belani, Joel N. Saltzman, Nathan A. Pennell, Gopakumar S. Nambudiri, John McCann, Jerome D. Winegarden, Mohammed ...> ;Journal of Clinical Oncology. 2019 Jul 30
20 citations
Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy.
Suzanne McMullen, Lisa M. Hess, Edward S. Kim, Benjamin Levy, Mohamed K. Mohamed, David M. Waterhouse, Antoinette J. Wozniak, Sarah Goring, Kerstin Müller, Catherine M...> ;The Patient. 2019 Apr 1
13 citations
Safety profile of nivolumab administered as 30-min infusion: analysis of data from CheckMate 153
David M. Waterhouse, Leora Horn, Craig H. Reynolds, David R. Spigel, Jason C. Chandler, Tarek Mekhail, Mohamed K. Mohamed, Ben C. Creelan, Kenneth B. Blankstein, Petro...> ;Cancer Chemotherapy and Pharmacology. 2018 Feb 13
1 citations
P2.33: Safety Profile of Nivolumab Administered as 30-Minute (MIN) Infusion: Analysis of Data From Checkmate 153: Track: Immunotherapy
David M. Waterhouse, Leora Horn, Craig H. Reynolds, David R. Spigel, Jason C. Chandler, Tarek Mekhail, Mohamed K. Mohamed, Ben C. Creelan, Kenneth B. Blankstein, Petro...> ;Journal of Thoracic Oncology. 2016 Oct 1
26 citations
Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular Testing
Alexa B. Schrock, Garrett M. Frampton, Dana Herndon, Joel R. Greenbowe, Kai Wang, Doron Lipson, Roman Yelensky, Zachary R. Chalmers, Juliann Chmielecki, Julia A. Elvin...> ;Clinical Cancer Research. 2016 Mar 1
24 citations
Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations
Benjamin Levy, Marc D. Chioda, Dana Herndon, John W. Longshore, Mohamed K. Mohamed, Sai-Hong Ignatius Ou, Craig H. Reynolds, Jaspal Singh, Ignacio I. Wistuba, Paul A. ...> ;The Oncologist. 2015 Oct 1
61 citations
Southwest Oncology Group S0802: A Randomized, Phase II Trial of Weekly Topotecan With and Without Ziv-Aflibercept in Patients With Platinum-Treated Small-Cell Lung Cancer
Jeffrey Warren Allen, James C. Moon, Mary W. Redman, Shirish M. Gadgeel, Karen Kelly, Philip C. Mack, Hanna M. Saba, Mohamed K. Mohamed, Mohammad Jahanzeb, David R. Ga...> ;Journal of Clinical Oncology. 2014 Aug 10
Join now to see all